Clinical characteristics of the treatment-naive eyes after the first treatment cycle and at the last follow-up visit
| Subgroup characteristics after the first treatment cycle | |
| Mean BCVA in logMAR scale (SD) | 0.3 (0.37) |
| Mean time to dry in days (range) | 130.3 (0–562) |
| Eyes with hyperautofluorescent ring on FAF (%) | 23 (36.5) |
| Subgroup characteristics at last follow-up | |
| Mean BCVA in logMAR scale (SD) | 0.3 (0.40) |
| Mean follow-up in days (range) | 748 (41–1991) |
| Lens status | |
| Phakic (%) | 21 (32.8) |
| Pseudophakic (%) | 43 (67.2) |
| Mean number of cycles (range) | 2.5 (1–7) |
| Eyes with hyperautofluorescent ring in FAF (%) | 25 (39) |
BCVA, best-corrected visual acuity; FAF, fundus autofluorescence; logMAR, logarithm of the minimum angle of resolution.